ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Rheumatology

Top Rheumatology Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS MCGEE M.D.

Rheumatology

15,322

$999K

710
577 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $117

RUNAS POWERS MD

Rheumatology

9,061

$689K

467
318 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$76
Average prescription price

Avg: $117

EDMUND LACOUR M.D.

Rheumatology

8,165

$1.3M

666
370 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$159
Average prescription price

Avg: $117

WILLIAM SULLIVAN MD

Rheumatology

8,149

$1.28M

820
562 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$157
Average prescription price

Avg: $117

JAMES JAKES MD

Rheumatology

8,119

$755K

626
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$93
Average prescription price

Avg: $117

VISHALA CHINDALORE M.D.

Rheumatology

7,990

$523K

643
353 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $117

CHRISTOPHER ADAMS M.D.

Rheumatology

7,900

$1.15M

671
383 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$145
Average prescription price

Avg: $117

RICHARD JONES MD

Rheumatology

7,539

$850K

733
366 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$113
Average prescription price

Avg: $117

R. MACON PHILLIPS M.D.

Rheumatology

7,420

$1.36M

753
526 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$183
Average prescription price

Avg: $117

JAMES LAWRENCE MD

Rheumatology

7,035

$767K

395
111 are 65+

28%
patients receiving schedule two controlled substances

Avg: 3%

58%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $117

PARKS PRATT MD

Rheumatology

6,453

$1.31M

672
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$203
Average prescription price

Avg: $117

WILLIAM SHERGY M.D.

Rheumatology

6,326

$1.03M

725
508 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 18%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 22%

$163
Average prescription price

Avg: $117

JOHN MORGAN MD

Rheumatology

6,052

$981K

586
359 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

39%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$162
Average prescription price

Avg: $117

GREG EUDY MD PC

Rheumatology

5,953

$1.14M

366
216 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 22%

$192
Average prescription price

Avg: $117

MAURA KENNEDY MD

Rheumatology

5,853

$557K

365
235 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 18%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$95
Average prescription price

Avg: $117

PETER SAWAY MD

Rheumatology

5,790

$517K

401
261 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$89
Average prescription price

Avg: $117

WILLIAM PAUL MD

Rheumatology

5,771

$525K

423
299 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$91
Average prescription price

Avg: $117

ROBERT HUNT M.D.

Rheumatology

5,490

$565K

543
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$103
Average prescription price

Avg: $117

JEFFREY FAGGARD M.D

Rheumatology

5,345

$494K

498
267 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

36%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $117

SOHRAB FALLAHI

Rheumatology

5,207

$684K

576
365 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 22%

$131
Average prescription price

Avg: $117

ELIZABETH PERKINS MD

Rheumatology

5,100

$356K

374
215 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $117

CORNELIUS THOMAS MD

Rheumatology

5,054

$168K

322
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 22%

$33
Average prescription price

Avg: $117

WALTER CHATHAM MD

Rheumatology

4,918

$520K

333
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$106
Average prescription price

Avg: $117

MARY ALTZ-SMITH MD

Rheumatology

4,864

$383K

241
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$79
Average prescription price

Avg: $117

THOMAS TRAYLOR MD

Rheumatology

4,862

$445K

364
271 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$91
Average prescription price

Avg: $117

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank